scispace - formally typeset
J

Jim Todd

Researcher at University of London

Publications -  482
Citations -  21825

Jim Todd is an academic researcher from University of London. The author has contributed to research in topics: Population & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 75, co-authored 472 publications receiving 20548 citations. Previous affiliations of Jim Todd include National Institute for Health Research & Colorado School of Public Health.

Papers
More filters
Journal ArticleDOI

Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial

TL;DR: It is concluded that improved STD treatment reduced HIV incidence by about 40% in this rural population of Tanzania, the first randomised trial to demonstrate an impact of a preventive intervention on HIV incidence in a general population.
Journal ArticleDOI

Toxic-shock syndrome associated with phage-group-I Staphylococci.

TL;DR: One patient died, one had gangrene of the toes, and all have had fine desquamation of affected skin and peeling of palms and soles during convalescence.
Journal ArticleDOI

Defining the Group A Streptococcal Toxic Shock Syndrome: Rationale and Consensus Definition

TL;DR: Group A streptococcal infections characterized by signs including shock, multi—organ system involvement, and rapidly progressive, destructive soft-tissue infection (necrotizing fasciitis) even though most patients received appropriate antimicrobial therapy, supportive care, and, where necessary, surgical debridement.
Journal ArticleDOI

Biological and behavioural impact of an adolescent sexual health intervention in Tanzania: a community-randomized trial.

TL;DR: The intervention substantially improved knowledge, reported attitudes and some reported sexual behaviours, especially in boys, but had no consistent impact on biological outcomes within the 3-year trial period.
Journal ArticleDOI

Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection.

TL;DR: This retrospective study suggests that clindamycin in combination with a beta-lactam antibiotic (with surgery if indicated) might be the most effective treatment for invasive S. pyogenes infection.